171
Views
0
CrossRef citations to date
0
Altmetric
Research Article

The Development and Content Validity of the Assessment of Written Expression Adaptivity for Assistive Technology

& ORCID Icon
Pages 516-529 | Received 02 Jul 2022, Accepted 14 Aug 2022, Published online: 26 Aug 2022
 

ABSTRACT

The Assessment of Written Expression Adaptivity for Assistive Technology (AWE ADAPT for AT) was developed to examine written expression participation in high school-age clients to aid the identification of assistive technology (AT) tools that can be recommended to optimize written expression. The tool is guided by the Occupational Adaptation (OA) model and measures the constructs of relative mastery (i.e., client’s perceptions regarding effectiveness, efficiency, and satisfaction) and adaptive capacity (i.e., perceived helpfulness of existing strategies) as they relate to written expression participation. The purpose of this study was to evaluate the content validity of the AWE ADAPT for AT. Seven content experts were recruited and five reviewed the assessment to determine the item-level content validity index (I-CVI) and scale-level index (S-CVI). The content experts agreed that 28 of the 30 assessment items were essential in assessing written expression participation as noted by an I-CVI score of 0.80 and higher. A scale-level content validity (S-CVI) of 0.92 also established the AWE ADAPT for AT as a content valid measure of written expression participation. After content validation, this tool is now ready for analysis of clinical utility and future construct validation.

Acknowledgments

The researchers would like to thank the participating content experts who participated in this study.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

The author(s) reported there is no funding associated with the work featured in this article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.